All citizens of Mali are at risk of contracting malaria. Malaria is one of
the principle causes of death and suffering in Mali. It is responsible for
more than 30 percent2 of all outpatient visits and 30 percent of hospital
deaths.
Mali is one of eight new third-round target countries benefiting from
the President's Malaria Initiative (PMI), a five-year, $1.2 billion program
led by the U.S. Agency for International Development (USAID), in conjunction
with the Department of Health and Human Services (Centers
for Disease Control and Prevention), the Department of State, and the
White House.
Goal
The goal of the PMI is to cut malaria deaths by 50 percent in 15 countries
in Africa by reaching 85 percent of the most vulnerable groups – principally
pregnant women, children under 5 years of age, and persons living
with HIV/AIDS – with lifesaving services, supplies, and medicines.
PMI coordinates with national malaria control programs and international
partners, including the Global Fund to Fight AIDS, Tuberculosis and
Malaria; the World Bank Malaria Booster Program; the Roll Back Malaria
partnership; nongovernmental organizations; faith-based and community
groups; and the private sector.
Key Interventions
In support of Mali's national malaria control program, the PMI backs
four key intervention strategies to prevent and treat malaria:
• Spraying with insecticides (“indoor residual spraying,” or IRS)
• Insecticide-treated mosquito nets (ITNs)
• Lifesaving drugs
• Treatment for pregnant women (“intermittent preventive
treatment,” or IPT)
Back to President's Initiatives
President's Malaria Initiative (PMI) Fast Facts